IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.427
EU - Europa 2.892
AS - Asia 918
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 10.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.413
UA - Ucraina 658
IT - Italia 468
IE - Irlanda 448
SE - Svezia 391
CN - Cina 314
DE - Germania 288
SG - Singapore 280
DK - Danimarca 228
TR - Turchia 169
GB - Regno Unito 131
FI - Finlandia 127
KR - Corea 115
FR - Francia 109
CI - Costa d'Avorio 50
MA - Marocco 39
IN - India 21
BE - Belgio 16
CA - Canada 12
NL - Olanda 8
JP - Giappone 7
PL - Polonia 7
EU - Europa 6
EG - Egitto 5
IR - Iran 4
RS - Serbia 4
AT - Austria 3
RO - Romania 2
TW - Taiwan 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CU - Cuba 1
HK - Hong Kong 1
IS - Islanda 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
VN - Vietnam 1
Totale 10.340
Salva come PNG Salva come JPEG
Città #
Chandler 785
Jacksonville 711
Fairfield 605
Dublin 447
Ashburn 436
Des Moines 427
Boardman 392
Woodbridge 283
Wilmington 274
Houston 255
Seattle 222
Cambridge 211
New York 208
Centro 202
Lawrence 163
Princeton 163
San Mateo 151
Ann Arbor 125
Singapore 84
San Diego 83
Washington 56
Abidjan 50
Beijing 42
London 36
Guangzhou 34
Turin 31
Shanghai 27
Ancona 26
Los Angeles 26
Wuhan 22
Norwalk 17
Brussels 16
Helsinki 16
Marche 16
Pune 16
Wuxi 13
Dallas 12
Jiaxing 12
Torre Annunziata 10
Kilburn 9
Falls Church 7
Izmir 7
Ottawa 7
Appignano 6
Civitanova Marche 6
New Bedfont 6
Redmond 6
Senigallia 6
Andover 5
Quanzhou 5
Belgrade 4
Florence 4
Jinhua 4
Milan 4
Naaldwijk 4
Nanjing 4
Padova 4
Palermo 4
Porto 4
Rome 4
Shaoxing 4
Shenzhen 4
Southend 4
Squinzano 4
Acton 3
Cairo 3
Chicago 3
Chiswick 3
Edinburgh 3
Falerone 3
Jesi 3
Lunano 3
Naples 3
Prescot 3
Redwood City 3
Santa Clara 3
Seoul 3
Southwark 3
Toronto 3
Vienna 3
Yiwu 3
Amsterdam 2
Clifton 2
Falconara Marittima 2
Heze 2
Hounslow 2
Jinan 2
Laurel 2
Miami Beach 2
Perugia 2
Pesaro 2
Porto San Giorgio 2
Slobozia 2
Taichung 2
Taizhou 2
Venice 2
Zhengzhou 2
Zibo 2
Acquaviva Picena 1
Ascoli Piceno 1
Totale 6.918
Salva come PNG Salva come JPEG
Nome #
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 141
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 117
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 110
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 102
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 102
Hepatitis E in a region of Italy: An emerging autochthonous infection? 100
Descriptive epidemiology of cholangiocarcinoma in Italy. 97
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 97
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 96
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 95
Clinical implications of novel aspects of biliary pathophysiology. 94
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 94
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 92
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 91
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 90
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 90
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 89
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 88
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 88
Cholangiocarcinoma development: the resurgence of bile acids 87
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 86
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 86
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 83
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 83
Functional and Structural Features of Cholangiocytes in Health and Disease 83
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 82
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 82
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 81
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 80
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 80
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 80
Current targets for Primary Sclerosing cholangitis 80
Functional heterogeneity of the intrahepatic biliary tree 79
Leptin enhances cholangiocarcinoma cell growth. 78
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 78
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 78
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 78
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 78
Role of apoptosis in development of primary biliary cirrhosis 77
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 77
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 77
Aging and the Biological Response to Liver Injury 76
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 75
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 74
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 74
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 74
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 73
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 73
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 73
Development and functional characterization of extrahepatic cholangiocyte lines from normal rats 73
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 72
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats 71
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 71
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 71
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 71
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 69
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 69
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 69
Role of cholangiocytes in primary biliary cirrhosis 69
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 69
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 68
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 68
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 68
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 67
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 67
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 67
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 67
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 67
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 67
NUOVA METODICA DIAGNOSTICA PER LE NEOPLASIE DEL PANCREAS 66
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 66
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 66
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 66
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 65
Primary Biliary Cholangitis: advances in management and treatment of the disease 65
Small Mouse cholangiocytes proliferate in response to H1 Histamine receptor stimulation by activation of the IP3/CAMK I/CREB pathway. 64
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 64
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 64
Cholangiocytes in health and disease: From basic science to novel treatments 64
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt 63
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 63
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 62
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 62
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 62
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 62
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 62
Polycystic liver diseases: advanced insights into the molecular mechanisms 61
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 61
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances 61
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 61
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte proliferation and secretion of bile duct ligated rats through activation of PKC alpha. 60
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 60
Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP 59
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 59
Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity. 59
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 59
Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice 59
The significance of genetics for cholangiocarcinoma development 58
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases 58
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 58
Totale 7.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020740 0 0 0 2 136 4 141 0 148 33 57 219
2020/20212.374 129 250 303 63 283 142 186 189 208 244 229 148
2021/20221.384 72 356 19 37 15 68 80 85 68 100 223 261
2022/20232.548 215 204 144 196 158 623 4 165 616 13 161 49
2023/20241.542 254 34 118 306 245 328 16 29 11 28 10 163
2024/2025723 328 284 107 4 0 0 0 0 0 0 0 0
Totale 10.716